Amended classification of renal tumours 2013 (International Society of Urological Pathology Vancouver Classification of Renal Neoplasia)
Authors:
Milan Hora 1; Tomáš Ürge 1; Kristýna Kalusová 1; Michal Michal 2; Zdeněk Chudáček 3; Jiří Ferda 4; Ondřej Hes 2
Authors‘ workplace:
Urologická klinika LF UK a FN, Plzeň
1; Šiklův patologicko-anatomický ústav LF UK a FN, Plzeň
2; Radiodiagnostické oddělení FN, Plzeň
3; Klinika zobrazovacích metod FN, Plzeň
4
Published in:
Ces Urol 2014; 18(1): 9-20
Category:
Review article
Overview
Introduction:
Kidney tumours form a broad spectrum of histopathological entities. The last WHO classification was formulated in 2004. An actualized version was published in October 2013 by International Society of Urological Pathology. We present a summary of the substantial changes made, from the clinician’s point of view.
Overview:
Five epithelial tumours: tubulocystic renal cell carcinoma (RCC), acquired cystic disease-associated RCC, clear cell (tubulo) papillary RCC, MiT family translocation RCCs (in particular t(6;11) RCC), and hereditary leiomyomatosis RCC syndrome-associated RCC, were added to the classification. In addition, three RCCs, thyroid-like follicular RCC; succinate dehydrogenase B deficiency-associated RCC; and ALK translocation RCC, were added as provisional entities. Some modifications were made in existing entities: Multicystic clear cell RCC (formerly multilocular cstic RCC) has been logically included into a subcategory of clear CRCC, as a tumour with low malignant potential. Oncocytic papillary RCC (PRCC) wasn’t accepted as a distinctive subcategory of PRCC. Hybrid oncocytic chromophobe tumour, which exists in 3 clinical and pathological forms; Birt-Hogg-Dubé Syndrome, renal oncocytosis, and as a sporadic neoplasm, was classified within the chromophobe RCC category. Recent new findings related to RC origin; collecting duct carcinoma, renal medullary carcinoma, and mucinous spindle cell and tubular RCC, were included. New insights into angiomyolipoma, including the epithelioid and epithelial cystic variants, were summarized as well. Cystic nephroma, and mixed epithelial and stromal tumour, were combined into one category. Synovial sarcoma was placed within the sarcoma group. The new classification is referred to as the International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia.
Conclusion:
Urologists should be educated in ISUP Vancouver Classification of Renal Neoplasia, as it contains a lot of substantial changes compared to the 2004 WHO classification and we predict that it will become a basis for the new WHO classification.
Key words:
renal tumours, classification.
Sources
1. Eble JN SG, Epstein JI, et al. (eds.) Pathology and genetics of tumours of the urinary system and male genital organs. In: World Health Organization Classification of Tumours. Lyon: IARC Press 2004.
2. Srigley JR, Delahunt B, Eble JN, Egevad L, Epstein JI, Grignon D, et al. The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia. The American journal of surgical pathology 2013; 37(10): 1469–1489.
3. Hora M, Hes O. Histologie nádorů ledvin dospělých. Ces Urol 1998; 2(5): 29–32.
4. Hora M, Urge T, Eret V, Stransky P, Klecka J, Kreuzberg B, et al. Tubulocystic renal carcinoma: a clinical perspective. World journal of urology 2011; 29(3): 349–354.
5. Steiner P, Hora M, Stehlik J, Martinek P, Vanecek T, Petersson F, et al. Tubulocystic renal cell carcinoma: is there a rational reason for targeted therapy using angiogenic inhibition? Analysis of seven cases. Virchows Archiv: an international journal of pathology 2013; 462(2): 183–192.
6. Hora M, Hes O, Reischig T, Urge T, Klecka J, Ferda J, et al. Tumours in end-stage kidney. Transplant Proc 2008; 40(10): 3354–3358.
7. Michal M, Hes O, Nemcova J, Sima R, Kuroda N, Bulimbasic S, et al. Renal angiomyoadenomatous tumor: morphologic, immunohistochemical, and molecular genetic study of a distinct entity. Virchows Archiv: an international journal of pathology 2009; 454(1): 89–99.
8. Michal M, Hes O, Kuroda N, Kazakov DV, Hora M. Difference between RAT and clear cell papillary renal cell carcinoma/clear renal cell carcinoma. Virchows Archiv: an international journal of pathology 2009; 454(6): 719.
9. Hora M, Hes O, Eret V, Ürge T, Klečka J, Ferda J, et al. Translokační renální karcinom Xp11. 2 typu ASPL/TFE3 (kidney carcinoma associated with Xp11.2 translocation type ASPL/TFE3). Ces Urol 2008; 12(3): 186–193.
10. Kalusová K, Hora M, Ürge T, Trávníček I, Eret V, Ferda J, et al. C03 MiT translocation renal cell carcinoma – a subset of tumours with translocation 6p21 [t (6; 11)] or Xp11. 2 [t (X; 1 or X or 17)]. European Urology Supplements 2013; 12(4): e1111, C03.
11. Hora M, Hes O, Ürge T, Eret V, Klečka J, Michal M. A distinctive translocation carcinoma of the kidney [„rosette-like forming“ t(6;11), HMB45-positive renal tumor]. Int Urol Nephrol 2009; 41(3): 553–557.
12. Petersson F, Vanecek T, Michal M, Martignoni G, Brunelli M, Halbhuber Z, et al. A distinctive translocation carcinoma of the kidney; „rosette forming“ t(6;11), HMB45-positive renal tumor: a histomorphologic, immunohistochemical, ultrastructural, and molecular genetic study of 4 cases. Human pathology 2012; 43(5): 726–736.
13. Przybycin CG, Magi-Galluzzi C, McKenney JK. Hereditary syndromes with associated renal neoplasia: a practical guide to histologic recognition in renal tumor resection specimens. Adv Anat Pathol 2013; 20(4): 245–263.
14. Branžovský J, Martínek P, Baulet K, Trávníček I, Stránský P, Vaneček T, et al. Využití molekulární genetiky v diferenciální diagnostice nádorů ledvin. Ces Urol 2012; 16(4): 214–221.
15. Grubb RL, 3rd, Franks ME, Toro J, Middelton L, Choyke L, Fowler S, et al. Hereditary leiomyomatosis and renal cell cancer: a syndrome associated with an aggressive form of inherited renal cancer. The Journal of urology 2007; 177(6): 2074–2079; discussion 9–80.
16. Ricketts CJ, Shuch B, Vocke CD, Metwalli AR, Bratslavsky G, Middelton L, et al. Succinate dehydrogenase kidney cancer: an aggressive example of the Warburg effect in cancer. The Journal of urology 2012; 188(6): 2063–2071.
17. Gill AJ, Pachter NS, Clarkson A, Tucker KM, Winship IM, Benn DE, et al. Renal tumors and hereditary pheochromocytoma-paraganglioma syndrome type 4. The New England journal of medicine 2011; 364(9): 885–886.
18. Gill AJ, Pachter NS, Chou A, Young B, Clarkson A, Tucker KM, et al. Renal tumors associated with germline SDHB mutation show distinctive morphology. The American journal of surgical pathology 2011; 35(10): 1578–1585.
19. Sukov WR, Hodge JC, Lohse CM, Akre MK, Leibovich BC, Thompson RH, et al. ALK alterations in adult renal cell carcinoma: frequency, clinicopathologic features and outcome in a large series of consecutively treated patients. Modern pathology: an official journal of the United States and Canadian Academy of Pathology Inc. 2012; 25(11): 1516–1525.
20. Hora M, Hes O, Michal M, Boudová L, Chudáček Z, Kreuzberg B, et al. Extensively cystic renal neoplasms in adults (Bosniak classification II or III)-possible „common“ histological diagnoses: multilocular cystic renal cell carcinoma, cystic nephroma, and mixed epithelial and stromal tumor of the kidney. Int Urol Nephrol 2005; 37(4): 743–750.
21. Ürge T, Hes O, Ferda J, Chudáček Z, Eret V, Michal M, et al. Typical signs of oncocytic papillary renal cell carcinoma in everyday clinical praxis. World journal of urology 2010; 28(4): 513–517.
22. Petersson F, Gatalica Z, Grossmann P, Perez Montiel MD, Alvarado Cabrero I, Bulimbasic S, et al. Sporadic hybrid oncocytic/chromophobe tumor of the kidney: a clinicopathologic, histomorphologic, immunohistochemical, ultrastructural, and molecular cytogenetic study of 14 cases. Virchows Archiv: an international journal of pathology 2010; 456(4): 355–365.
23. Hes O, Hora M, Perez-Montiel DM, Suster S, Curík R, Sokol L, et al. Spindle and cuboidal renal cell carcinoma, a tumour having frequent association with nephrolithiasis: report of 11 cases including a case with hybrid conventional renal cell carcinoma/spindle and cuboidal renal cell carcinoma components. Histopathology 2002; 41(6): 549–555.
24. Ürge T HM, Hes O, Eret V, Stransky P, Travnicek I, Chudacek Z, Betlach J, Curik R, Rousarova M, Petersson F. Spindle and cuboidal renal cell carcinoma: Clinical results and long term follow up. Eur Urol Suppl 2013; 14(4): e1111.
25. Ürge T, Hora M, Hes O, Chudáček Z. Renal angiomyolipoma, histology, diagnostics and therapy. Čas. Lék. čes. 2005; 144(12): 821–823; 4.
26. Hora M, Michal M, Hes O. Re: Rodolfo Montironi, Roberta Mazzuccelli, Antonio Lopez-Beltran, et al. Cystic nephroma and mixed epithelial and stromal tumour of the kidney: opposite ends of the spectrum of the same entity? Eur Urol 2008; 54: 1237–1346. European urology 2009; 56(1): e3.
27. Michal M, Hes O, Kuroda N, Kazakov DV, Petersson F, Hora M, et al. What is a cystic nephroma? The American journal of surgical pathology 2010; 34(1): 126–127.
Labels
Paediatric urologist Nephrology UrologyArticle was published in
Czech Urology
2014 Issue 1
Most read in this issue
- Leydig cell tumor
- Benign retroperitoneal schwannoma
- Leydig cell tumor of the testis
- Squamous cell carcinoma of the renal pelvis